Lv51
1240 积分 2022-07-12 加入
Study protocol for a multi-institutional randomized phase III study comparing combined everolimus plus lanreotide therapy and everolimus monotherapy in patients with unresectable or recurrent gastroenteropancreatic neuroendocrine tumors; Japan Clinical Oncology Group Study JCOG1901 (STARTER-NET study)
11天前
已完结
Clinical pharmacology, efficacy, and safety of selexipag for the treatment of pulmonary arterial hypertension
18天前
已完结
Selexipag, a selective prostacyclin receptor agonist in pulmonary arterial hypertension: a pharmacology review
18天前
已完结
An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry
1个月前
已完结
Pharmacodynamics of transdermal granisetron in women with nausea and vomiting of pregnancy
2个月前
已完结
Pharmacokinetics and safety of transdermal and oral granisetron in healthy Chinese subjects: An open-label, randomized, crossover study
2个月前
已完结
Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
2个月前
已完结
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
3个月前
已完结
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data
7个月前
已完结
皖公网安备34019202002308
